US 5,627,023 A · Suppressor of HIV replication and transcription

Abstract

The present invention relates to a bioactive molecule, herein referred to as the CD8 suppressor molecule, that is produced by the CD8 subset of human T-lymphocytes and suppresses type-1 human immunodeficiency virus (HIV-1) replication through inhibition of vital transcription. The invention relates to isolation of clonal CD8 cells lines that produce the antiviral activity and the development of an assay system for detection of the antiviral activity. The clonal cell lines and the assay system, described herein, may be utilized to purify, characterize and clone the CD8 suppressor molecule. The CD8 suppressor molecule may have therapeutic applications for treatment of diseases associated with HIV-1 infection.

Claims5

Dependent claims

A method for detecting a CD8 suppressor molecule that has anti-HIV activity, comprising:

(a) culturing a host cell line transfected with a recombinant DNA expression vector in which a reporter gene is operatively associated with an HIV LTR promoter sequence;
(b) contacting the cell line with a sample comprising enriched CD8 cells or cell cultures of CD8 cells;
and
(c) measuring the inhibition of reporter gene activity, wherein inhibition of reporter gene activity correlates with anti-HIV activity.

1 more element

Dependencies are inferred from the claim text.

Suppressor of HIV replication and transcription

Life of this patent

Suppressor of HIV replication and transcription

Life of this patent

Abstract

Claims5